| scholarly article | Q13442814 |
| P50 | author | Lucy Anne Parker | Q43501499 |
| P2093 | author name string | Kenneth S K Tung | |
| Colin P Sharp | |||
| Eileen T Samy | |||
| P2860 | cites work | Mater, a maternal effect gene required for early embryonic development in mice | Q28588588 |
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
| Persistence of physiological self antigen is required for the regulation of self tolerance | Q30305547 | ||
| Endogenous oocyte antigens are required for rapid induction and progression of autoimmune ovarian disease following day-3 thymectomy | Q30307039 | ||
| Regulatory T-cell, endogenous antigen and neonatal environment in the prevention and induction of autoimmune disease | Q30308291 | ||
| CD40 ligand in pathogenesis of autoimmune ovarian disease of day 3-thymectomized mice: implication for CD40 ligand antibody therapy | Q30310493 | ||
| Maternal Autoantibody Triggers De Novo T Cell-Mediated Neonatal Autoimmune Disease | Q30310790 | ||
| Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. | Q34032006 | ||
| Regulating the immune response to transplants. a role for CD4+ regulatory cells? | Q34241129 | ||
| Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis | Q34311395 | ||
| Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism | Q34392100 | ||
| In vivo instruction of suppressor commitment in naive T cells | Q34548023 | ||
| Human T regulatory cells can use the perforin pathway to cause autologous target cell death | Q34551876 | ||
| In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro | Q35171080 | ||
| Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells | Q35867877 | ||
| Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance | Q36352346 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| Peripheral autoantigen induces regulatory T cells that prevent autoimmunity | Q36367859 | ||
| Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice | Q36370868 | ||
| Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node | Q36371218 | ||
| Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo | Q36371283 | ||
| Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells | Q36371345 | ||
| Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. | Q36371658 | ||
| In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 | ||
| CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. | Q36399104 | ||
| Defective suppressor function of human CD4+ CD25+ regulatory T cells in autoimmune polyglandular syndrome type II | Q36399471 | ||
| Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus | Q36402576 | ||
| Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells | Q36402710 | ||
| Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes | Q40530227 | ||
| Expression of dual TCR on DO11.10 T cells allows for ovalbumin-induced oral tolerance to prevent T cell-mediated colitis directed against unrelated enteric bacterial antigens | Q40597298 | ||
| Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes | Q40665485 | ||
| Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells | Q40969391 | ||
| Organ-specific autoimmunity induced by lymphopenia. | Q41326986 | ||
| Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
| Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy | Q42971266 | ||
| Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy | Q45871925 | ||
| Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells | Q47240621 | ||
| Immune regulation by self-reactive T cells is antigen specific. | Q47914976 | ||
| Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo. | Q47992041 | ||
| Peripheral expansion of thymus-derived regulatory cells in anti-myelin basic protein T cell receptor transgenic mice. | Q51032566 | ||
| Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells | Q56902811 | ||
| Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen | Q56902816 | ||
| Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy | Q67701322 | ||
| Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells | Q71403620 | ||
| Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens | Q72803264 | ||
| Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
| Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo | Q77342616 | ||
| Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells | Q77584357 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression | Q77995835 | ||
| Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells | Q79317453 | ||
| Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors | Q80444910 | ||
| CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector | Q80460622 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymph node | Q170758 |
| autoimmune disease | Q8084905 | ||
| P304 | page(s) | 771-781 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node | |
| P478 | volume | 202 |
| Q38556802 | A bacteriophages journey through the human body. |
| Q28972322 | A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency |
| Q36166154 | An MHC-linked locus modulates thymic differentiation of CD4+CD25+Foxp3+ regulatory T lymphocytes |
| Q38817090 | Anti-regulatory T cells |
| Q37403114 | Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma |
| Q34601484 | Antigen-specific peripheral shaping of the natural regulatory T cell population |
| Q43498496 | Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches |
| Q35001314 | Autoimmune oophoritis with multiple molecular targets mitigated by transgenic expression of mater |
| Q92051108 | Autologous activated platelet-rich plasma injection into adult human ovary tissue: molecular mechanism, analysis, and discussion of reproductive response |
| Q92132618 | Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |
| Q89433515 | CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse |
| Q79629254 | CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive |
| Q50784115 | CD4+ Foxp3+ regulatory T cells in autoimmune orchitis: phenotypic and functional characterization. |
| Q36386905 | CD4+CD25+ regulatory T lymphocytes in bone marrow transplantation |
| Q92451430 | CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells |
| Q36693344 | Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma |
| Q37164493 | Commonality in the genetic control of Type 1 diabetes in humans and NOD mice: variants of genes in the IL-2 pathway are associated with autoimmune diabetes in both species |
| Q34381839 | Continuous requirement for the TCR in regulatory T cell function |
| Q37026641 | Creating immune privilege: active local suppression that benefits friends, but protects foes. |
| Q35116303 | Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? |
| Q30436124 | Cutting edge: normal regional lymph node enrichment of antigen-specific regulatory T cells with autoimmune disease-suppressive capacity |
| Q26801029 | Deletional and regulatory mechanisms coalesce to drive transplantation tolerance through mixed chimerism |
| Q36828887 | Dendritic Cells Coordinate the Development and Homeostasis of Organ-Specific Regulatory T Cells |
| Q36228938 | Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice |
| Q37294572 | Ex vivo expansion of CD4(+)CD25(+) T regulatory cells for immunosuppressive therapy |
| Q37331528 | Feedback control of regulatory T cell homeostasis by dendritic cells in vivo |
| Q64075115 | Foxp3 Regulatory and Conventional CD4 T Cells Display Similarly High Frequencies of Alloantigen-Reactive Cells |
| Q52624752 | Foxp3-independent loss of regulatory CD4+ T-cell suppressive capacities induced by self-deprivation. |
| Q36586957 | Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells |
| Q30429142 | H2 control of natural T regulatory cell frequency in the lymph node correlates with susceptibility to day 3 thymectomy-induced autoimmune disease |
| Q37028039 | HLA Class II tetramers reveal tissue-specific regulatory T cells that suppress T-cell responses in breast carcinoma patients |
| Q57275367 | High TCR diversity ensures optimal function andhomeostasis of Foxp3+regulatory Tcells |
| Q35767591 | Higher Sensitivity of Foxp3+ Treg Compared to Foxp3- Conventional T Cells to TCR-Independent Signals for CD69 Induction |
| Q26853599 | Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs |
| Q54427491 | Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire. |
| Q34749483 | IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis. |
| Q42065988 | Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients |
| Q35806782 | Immunity, cancer and aging: lessons from mouse models. |
| Q36449594 | Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice |
| Q36809762 | Indoleamine 2,3-dioxygenase and tumor-induced tolerance |
| Q33918375 | Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity |
| Q37864700 | Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/ B7 family |
| Q30441305 | Large functional repertoire of regulatory T-cell suppressible autoimmune T cells in scurfy mice |
| Q36073220 | Layers of dendritic cell-mediated T cell tolerance, their regulation and the prevention of autoimmunity |
| Q40349858 | Lymph node trafficking of regulatory T cells is prerequisite for immune suppression |
| Q28083298 | Manipulating regulatory T cells: a promising strategy to treat autoimmunity |
| Q36793315 | Mechanisms and models of immune tolerance breakdown in the ovary |
| Q27010198 | Organ-specific and memory treg cells: specificity, development, function, and maintenance |
| Q26823517 | Ovarian autoimmune disease: clinical concepts and animal models |
| Q46584678 | Phenotypic analysis of human peripheral blood regulatory T cells (CD4+FOXP3+CD127lo/-) ex vivo and after in vitro restimulation with malaria antigens |
| Q37861405 | Physiologic control of the functional status of Foxp3+ regulatory T cells |
| Q30438368 | Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+ CD25+ regulatory T cells |
| Q48306782 | Profiling the lymphoid-resident T cell pool reveals modulation by age and microbiota. |
| Q30573918 | Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance |
| Q37474900 | Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells |
| Q30440063 | Regulation of multi-organ inflammation in the regulatory T cell-deficient scurfy mice |
| Q37981391 | Regulatory T cell migration during an immune response |
| Q36534827 | Regulatory T cells and innate immune regulation in tumor immunity |
| Q30409844 | Regulatory T cells and vasectomy |
| Q38071649 | Regulatory T cells are baby's best friends |
| Q30429858 | Regulatory T cells control tolerogenic versus autoimmune response to sperm in vasectomy |
| Q37963308 | Regulatory T cells essential to prevent the loss of self-tolerance in murine models of erythrocyte-specific autoantibody responses |
| Q35621984 | Regulatory T cells for tolerance therapy: revisiting the concept |
| Q34547120 | Regulatory T cells in experimental autoimmune disease |
| Q91045864 | Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells |
| Q37452133 | Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis |
| Q36212936 | Regulatory T cells that recognize a ubiquitous stress-inducible self-antigen are long-lived suppressors of autoimmune arthritis |
| Q37302327 | Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? |
| Q27022973 | Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression |
| Q34510690 | Reinterpretation of evidence advanced for neo-oogenesis in mammals, in terms of a finite oocyte reserve |
| Q42536113 | Requirement for diverse TCR specificities determines regulatory T cell activity in a mouse model of autoimmune arthritis |
| Q41592357 | Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome |
| Q37090518 | Role of regulatory T cells in gastrointestinal inflammatory disease |
| Q64122265 | Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease |
| Q56899105 | SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3 |
| Q37809744 | Shaping the T-cell repertoire in the periphery |
| Q34003592 | Shaping the repertoire of tumor-infiltrating effector and regulatory T cells |
| Q35833271 | Stem cells, progenitor cells, and lineage decisions in the ovary |
| Q36021368 | Structural, cellular and molecular aspects of immune privilege in the testis |
| Q40355426 | Suppression of lethal autoimmunity by regulatory T cells with a single TCR specificity |
| Q26749508 | T cell receptor signalling in the control of regulatory T cell differentiation and function |
| Q35836118 | T cells in the control of organ-specific autoimmunity |
| Q61445444 | T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field |
| Q37800935 | T regulatory cells in cancer: recent advances and therapeutic potential |
| Q38202989 | T-cell selection and intestinal homeostasis |
| Q37947987 | TCR diversity and Treg cells, sometimes more is more. |
| Q36922740 | Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells |
| Q48358940 | The mechanisms shaping the repertoire of CD4+ Foxp3+ regulatory T cells. |
| Q30441254 | The role of physiological self-antigen in the acquisition and maintenance of regulatory T-cell function |
| Q36593753 | The tumor-draining lymph node as an immune-privileged site |
| Q52584757 | Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin. |
| Q37695519 | tTregs, pTregs, and iTregs: similarities and differences |
Search more.